HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$1.20
Day range
$1.18 - $1.31
Year range
$0.57 - $2.58
Market cap
211.60M USD
Avg Volume
3.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.20M | -1.48% |
Net income | -19.13M | 34.27% |
Net profit margin | — | — |
Earnings per share | -0.10 | 65.52% |
EBITDA | -25.14M | 1.24% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 114.22M | -6.16% |
Total assets | 147.26M | -5.35% |
Total liabilities | 96.16M | 17.94% |
Total equity | 51.10M | — |
Shares outstanding | 167.94M | — |
Price to book | 3.87 | — |
Return on assets | -39.31% | — |
Return on capital | -53.56% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -19.13M | 34.27% |
Cash from operations | -27.75M | -45.33% |
Cash from investing | -4.83M | -14,114.71% |
Cash from financing | 97.00K | -99.84% |
Net change in cash | -32.36M | -177.26% |
Free cash flow | -18.34M | -94.02% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
93